Excavating Traditional Excellent Traditional Chinese Medicine Formulas to Explore the Path to Creating Chinese New Drugs

Business Club September 17th September 10th, 2010, “Beidaihe Sanitarium Pharmaceutical Co., Ltd. to transfer the results of nephritis Qingfang signing ceremony” was officially held in the beautiful resort Beidaihe. Deputy Director Tu Guozheng of the Political Department of the Joint Logistics Department of the Beijing Military Region, Deputy Minister Shen Chengmin of the Ministry of Health of the Beijing Military Region, Director of the Beidaihe Sanitation Center Shen Chunquan, Political Committee of Anzi Li, Director Zhou Zhuliang of the Kidney Center of Beidaihe Sanatorium, and Chairman Yan Xijun of Tasly Pharmaceutical Co., Ltd. attended ceremony.

At the ceremony, Tasly Pharmaceutical Co., Ltd., a nephritis treatment center that has been used clinically for more than 30 years in the entire army nephropathy center, was used to develop new drug developments. It revealed that Tasly is accelerating with the military and local medical units. Cooperation, the use of modern high-tech technology to develop excellent classics, clinical examination of the curtain.

Beidaihe Sanatorium is an all-Kidney kidney disease center and has accumulated rich clinical experience as a hospital preparation. After Tasly Pharmaceutical Co., Ltd. introduced the prescription, it carried out in-depth development and comprehensive research. At present, there are preclinical studies such as toxicology and toxicology. It has been fully launched in the GLP laboratory and is expected to receive clinical approvals by the end of 2011. It will be awarded a new drug certificate by the end of 2014 and will add new forces to the Tasly series of modern Chinese medicines.

Chairman of Taslik Pharmaceutical Co., Ltd. Yan Xijun said: “This is not a simple transfer of achievements. It reminds people that there are huge treasures in the traditional Chinese medicine formula, which condenses the efforts of our medical workers for many years. Signing not only has respect for knowledge, but also represents a direction and a strategy for the development of innovative Chinese medicine in China. Whether this can be used to excavate good traditional Chinese medicines and develop new ones is related to the rejuvenation of traditional Chinese medicine.”

It is understood that the creation of new drugs has always been an important part of China's science and technology major projects. How to increase the R&D of existing excellent classical names and clinical prescriptions through systematic and standardized research and development into national new drugs in new drug discovery is a new path to be explored. . The nephritis group signed this time has already conducted a series of pharmacology, pharmacodynamics, toxicology, and clinical pre-experiments at Tasly Institute. After more than one year of systematic observation, it was found that nephritis Qingfang improves proteinuria, hematuria, and Diuretic showed good efficacy.

After more than ten years of unremitting efforts, Tasly has gradually formed its own unique research system on the research of component Chinese medicines. Tasly will inquire into the effective components of drugs through in-depth research and find out how to effectively control and By separating the optimal processes for these effective components, a series of patents and intellectual property rights are formed on the basis of clear preliminary understanding of the mechanism of action, and the development of innovative Chinese medicines will be carried out in accordance with the procedures and standards for the development of new drugs in China. The prescription is transformed into modern Chinese medicine preparations.

There are many outstanding prescriptions to be developed in the treasure chest of Chinese medicine's clinical prescriptions. Most of them have been used clinically for decades or even hundreds of years. After a large number of clinical trials have proved their effectiveness, the key is how to use modern scientific and technological means, according to international medicines. R&D standards develop it systematically. Only the joint efforts of industry, universities and research institutes to explore traditional treasures of traditional Chinese medicine can we explore a brand-new road for the creation of a new Chinese medicine, so that we can really revitalize the national pharmaceutical industry and make modern Chinese medicine work for the benefit of all humanity!